Kazia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.

About KZIA

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. 

CEO
John E. Friend
CEOJohn E. Friend
Employees
Employees
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1994
Founded1994
Employees
Employees

KZIA Key Statistics

Market cap
71.84M
Market cap71.84M
Price-Earnings ratio
-0.49
Price-Earnings ratio-0.49
Dividend yield
Dividend yield
Average volume
274.61K
Average volume274.61K
High today
High today
Low today
Low today
Open price
$6.14
Open price$6.14
Volume
0.00
Volume0.00
52 Week high
$17.40
52 Week high$17.40
52 Week low
$2.86
52 Week low$2.86

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.